Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and Critical Evaluation

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00445
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

State of the Art: Advances in Malignant Pleural Mesothelioma in 2017

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MicroRNAs as Potential Biomarkers in Malignant Pleural Mesothelioma

Current Biomarker Findings
BiochemistryClinical Biochemistry
2015English

Malignant Pleural Mesothelioma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

Heterogeneity in Malignant Pleural Mesothelioma

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Chemotherapy of Malignant Pleural Mesothelioma.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1990English

Disseminated Pleural Siliconoma Mimicking Malignant Pleural Mesothelioma

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2015English

Volumetric Assessment in Malignant Pleural Mesothelioma

Annals of Translational Medicine
Medicine
2017English

Pleural Fluid Analysis in Malignant Mesothelioma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1991English

Radiation Associated Malignant Pleural Mesothelioma.

Thorax
PulmonaryRespiratory Medicine
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy